InflaRx N.V. (IFRX) Discusses Topline Phase 2a Data in Chronic Spontaneous Urticaria and Hidradenitis Suppurativa Transcript

PresentationI would like to now turn the call over to Niels Riedemann, CEO and Founder of InflaRx. Niels, please go ahead.Good morning and good afternoon, everyone. Thank you for standing by, and thank you for joining our conference call to discuss our top line data for INF904 in HS and CSU. [Operator Instructions] And please note that today's call is being recorded. [Operator Instructions]Niels RiedemannCo-Founder, CEO & Executive Director Good morning, everyone. It's my pleasure to welcome you as well to ...